Outcome switching

Outcome switching refers to the practice in clinical research and clinical trials where the primary and secondary outcomes initially specified in the study protocol are changed after the trial has begun, without public documentation or justification. This practice can significantly impact the integrity of research findings, leading to biased results, compromised evidence for medical decision-making, and ultimately, it can affect patient care. Outcome switching is a critical issue in the fields of medicine, epidemiology, and health policy.

Background

In the context of clinical trials, outcomes are predefined objectives that researchers aim to measure to evaluate the effectiveness and safety of a medical intervention. These outcomes are usually divided into primary and secondary outcomes. The primary outcome is the most important one, directly related to the main question the trial seeks to answer, while secondary outcomes are additional effects of interest.

Before a clinical trial commences, researchers must register the study protocol, including detailed plans for how the study will be conducted and how the outcomes will be measured. This protocol is often registered in publicly accessible databases, such as ClinicalTrials.gov or the International Clinical Trials Registry Platform (ICTRP) managed by the World Health Organization (WHO).

Issues with Outcome Switching

Outcome switching undermines the credibility of clinical research in several ways:

• Bias: Changing outcomes based on the data observed during the trial can introduce bias, as researchers might be tempted to select outcomes that show the intervention in a more favorable light.
• Transparency: Lack of transparency about changes in outcomes can make it difficult for other researchers to replicate the study or for clinicians to make informed decisions based on the evidence.
• Waste: Resources spent on trials with switched outcomes could be considered wasted if the results are not reliable or if they do not contribute to the body of evidence in a meaningful way.

Addressing Outcome Switching

Several initiatives aim to address the issue of outcome switching and improve the transparency and reliability of clinical research findings:

• Trial registries: Mandatory registration of clinical trials and their protocols in public databases before the trial starts helps ensure that researchers adhere to their original plans or provide justifications for any changes.
• Reporting guidelines: Guidelines such as the CONSORT Statement (Consolidated Standards of Reporting Trials) encourage researchers to transparently report any changes to outcomes and the reasons for such changes.
• Research on research: Studies that investigate the prevalence and impact of outcome switching help raise awareness and inform policies to mitigate the issue.

Conclusion

Outcome switching poses a significant challenge to the integrity of clinical research. Efforts to increase transparency, adherence to pre-registered protocols, and enforcement of reporting guidelines are crucial steps toward ensuring that clinical trial findings are reliable and can be used to guide medical practice and health policy.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian